Activation of anti-oxidant Keap1/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation
Sina Bader, Julia Wilmers, Martin Pelzer, Verena Jendrossek, Justine Rudner
Topics & Concepts
Clonogenic assayKEAP1Cancer researchGlutathioneOxidative stressReactive oxygen speciesDihydroartemisininProgrammed cell deathCancer cellChemistryPharmacologyCell biologyCancerBiologyApoptosisBiochemistryImmunologyArtemisininEnzymeTranscription factorGeneMalariaPlasmodium falciparumGeneticsDrug Transport and Resistance MechanismsGenomics, phytochemicals, and oxidative stressParasites and Host Interactions